Literature DB >> 30370110

Editorial: refining the estimation of fitness for surgery.

Brienne Ryan1,2, Mark Hennon1,2, Sai Yendamuri1,2.   

Abstract

Year:  2018        PMID： 30370110      PMCID： PMC6186650          DOI： 10.21037/jtd.2018.08.35

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.

Authors:  Bjørg Sjøblom; Bjørn H Grønberg; Tore Wentzel-Larsen; Vickie E Baracos; Marianne J Hjermstad; Nina Aass; Roy M Bremnes; Øystein Fløtten; Asta Bye; Marit Jordhøy
Journal:  Clin Nutr       Date:  2016-04-01       Impact factor: 7.324

2.  Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.

Authors:  Yuzo Suzuki; Tatsuro Okamoto; Takatoshi Fujishita; Masakazu Katsura; Takaki Akamine; Shinkichi Takamori; Yosuke Morodomi; Tetsuzo Tagawa; Fumihiro Shoji; Yoshihiko Maehara
Journal:  Lung Cancer       Date:  2016-08-16       Impact factor: 5.705

3.  The influence of nutritional status on complications after operations for lung cancer.

Authors:  R T Jagoe; T H Goodship; G J Gibson
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

4.  A propensity-matched comparison of survival after lung resection in patients with a high versus low body mass index.

Authors:  Saina Attaran; James McShane; Ian Whittle; Michael Poullis; Michael Shackcloth
Journal:  Eur J Cardiothorac Surg       Date:  2012-04-19       Impact factor: 4.191

5.  Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.

Authors:  Ryota Nakamura; Yoshihisa Inage; Rika Tobita; Satoshi Yoneyama; Takeshi Numata; Kyoko Ota; Hidetoshi Yanai; Takeo Endo; Yukinori Inadome; Shingo Sakashita; Hiroaki Satoh; Kenji Yuzawa; Toru Terashima
Journal:  J Thorac Oncol       Date:  2018-05-08       Impact factor: 15.609

Review 6.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

Authors:  Julian R Molina; Ping Yang; Stephen D Cassivi; Steven E Schild; Alex A Adjei
Journal:  Mayo Clin Proc       Date:  2008-05       Impact factor: 7.616

7.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

Review 8.  The assessment and impact of sarcopenia in lung cancer: a systematic literature review.

Authors:  Jemima Collins; Simon Noble; John Chester; Bernadette Coles; Anthony Byrne
Journal:  BMJ Open       Date:  2014-01-02       Impact factor: 2.692

Review 9.  Sarcopenia and sarcopenic obesity.

Authors:  Kyung Mook Choi
Journal:  Korean J Intern Med       Date:  2016-11-01       Impact factor: 2.884

10.  Sarcopenia is a predictor of outcomes after lobectomy.

Authors:  James A Miller; Kassem Harris; Charles Roche; Samjot Dhillon; Athar Battoo; Todd Demmy; Chukwumere E Nwogu; Elisabeth U Dexter; Mark Hennon; Anthony Picone; Kristopher Attwood; Sai Yendamuri
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.